DK0596479T3 - Basofil-bindende monoklonalt antistof, fremgangsmåde til separation af basofiler, fremgangsmåde til frigivelse af kemisk fo - Google Patents

Basofil-bindende monoklonalt antistof, fremgangsmåde til separation af basofiler, fremgangsmåde til frigivelse af kemisk fo

Info

Publication number
DK0596479T3
DK0596479T3 DK93117830T DK93117830T DK0596479T3 DK 0596479 T3 DK0596479 T3 DK 0596479T3 DK 93117830 T DK93117830 T DK 93117830T DK 93117830 T DK93117830 T DK 93117830T DK 0596479 T3 DK0596479 T3 DK 0596479T3
Authority
DK
Denmark
Prior art keywords
basophils
release
separating
present
basophil
Prior art date
Application number
DK93117830T
Other languages
Danish (da)
English (en)
Inventor
Shinji Nishimura
Hiroshi Nishi
Masaji Nishimura
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of DK0596479T3 publication Critical patent/DK0596479T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4705Regulators; Modulating activity stimulating, promoting or activating activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0642Granulocytes, e.g. basopils, eosinophils, neutrophils, mast cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • C12N5/12Fused cells, e.g. hybridomas
    • C12N5/16Animal cells
    • C12N5/163Animal cells one of the fusion partners being a B or a T lymphocyte
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • G01N33/56972White blood cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00Methods for the dissociation of cells, e.g. specific use of enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK93117830T 1992-11-04 1993-11-03 Basofil-bindende monoklonalt antistof, fremgangsmåde til separation af basofiler, fremgangsmåde til frigivelse af kemisk fo DK0596479T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP32116492 1992-11-04

Publications (1)

Publication Number Publication Date
DK0596479T3 true DK0596479T3 (da) 1999-09-27

Family

ID=18129523

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93117830T DK0596479T3 (da) 1992-11-04 1993-11-03 Basofil-bindende monoklonalt antistof, fremgangsmåde til separation af basofiler, fremgangsmåde til frigivelse af kemisk fo

Country Status (9)

Country Link
US (1) US5500348A (ja)
EP (1) EP0596479B1 (ja)
JP (1) JP3550410B2 (ja)
KR (1) KR100280239B1 (ja)
AT (1) ATE176930T1 (ja)
DE (1) DE69323589T2 (ja)
DK (1) DK0596479T3 (ja)
ES (1) ES2129482T3 (ja)
TW (1) TW378213B (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6905680B2 (en) * 1988-11-23 2005-06-14 Genetics Institute, Inc. Methods of treating HIV infected subjects
US6352694B1 (en) * 1994-06-03 2002-03-05 Genetics Institute, Inc. Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells
US7479269B2 (en) * 1988-11-23 2009-01-20 Genetics Institute, Llc Methods for selectively enriching TH1 and TH2 cells
US6534055B1 (en) * 1988-11-23 2003-03-18 Genetics Institute, Inc. Methods for selectively stimulating proliferation of T cells
US7175843B2 (en) * 1994-06-03 2007-02-13 Genetics Institute, Llc Methods for selectively stimulating proliferation of T cells
US5722470A (en) * 1995-11-09 1998-03-03 Glaxo Group Limited Bead dispensing device and methods
DE19643427C1 (de) * 1996-10-22 1998-02-12 Bundesrep Deutschland Verfahren zur Bestimmung von Allergenen in der Luft
FR2765341A1 (fr) * 1997-06-25 1998-12-31 Alain Funes Methode pour l'analyse de l'activation des basophiles humains par mesure de l'expression membranaire du marqueur cd63
US6151973A (en) * 1999-01-29 2000-11-28 Glaxo Wellcome Inc. Bead picking apparatus and method
ES2230108T3 (es) * 1999-05-19 2005-05-01 Eberhard-Karls-Universitat Tubingen Universitatsklinikum Utilizacion de un anticuerpo para detectar basofilos y/o mastocitos.
WO2002003068A1 (fr) * 2000-06-30 2002-01-10 Kyowa Medex Co.,Ltd. Reactif de dosage immunologique nephelometrique a particules-supports insolubles
CN1215332C (zh) * 2000-07-27 2005-08-17 协和梅迪克斯株式会社 采用不溶性载体粒子的免疫测定方法、免疫测定试剂及其稳定化方法
US20030022250A1 (en) * 2001-05-29 2003-01-30 Dreskin Stephen C. Functional IgE test methods and compositions
US8242874B2 (en) * 2005-08-23 2012-08-14 Lear Corporation Electrical connector housing
CN112415191A (zh) * 2020-11-06 2021-02-26 郑州人福博赛生物技术有限责任公司 一种白细胞三烯检测试剂盒

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559310A (en) * 1983-05-20 1985-12-17 Dana Farber Cancer Institute Assay methods and systems utilizing mast cell clones
GB8607679D0 (en) * 1986-03-27 1986-04-30 Winter G P Recombinant dna product
FR2621128B1 (fr) * 1987-09-30 1994-05-06 Sanofi Trousse et methode de dosage immunometrique applicables a des cellules entieres
GB8916859D0 (en) * 1989-07-24 1989-09-06 Dynal As Hapten linking

Also Published As

Publication number Publication date
TW378213B (en) 2000-01-01
US5500348A (en) 1996-03-19
EP0596479A3 (en) 1995-04-19
JPH06205695A (ja) 1994-07-26
ES2129482T3 (es) 1999-06-16
KR100280239B1 (ko) 2001-02-01
DE69323589T2 (de) 1999-10-14
EP0596479B1 (en) 1999-02-24
KR940011480A (ko) 1994-06-21
JP3550410B2 (ja) 2004-08-04
DE69323589D1 (de) 1999-04-01
ATE176930T1 (de) 1999-03-15
EP0596479A2 (en) 1994-05-11

Similar Documents

Publication Publication Date Title
DK0596479T3 (da) Basofil-bindende monoklonalt antistof, fremgangsmåde til separation af basofiler, fremgangsmåde til frigivelse af kemisk fo
DK343679A (da) Immunologisk fremgangsmaade til bestemmelse af et immunkompleks i en vaeske samt det ved frmegangsmaaden anvendte diagnostiske middel
ATE98700T1 (de) Anti-fr-900506-stoffe-antikoerper und hoechstempfindliches enzym-immunoassay-verfahren.
DE69503903D1 (de) Positive und positive/negative zellselektion vermittelt durch peptiofreisetzung
CA2396116A1 (en) Immunochromatographic assay devices with separators
ATE292282T1 (de) Verfahren zur zellseparation unter verwendung von immunorosetten
NO970292D0 (no) Bestemmelse av et spesifikt immunoglobulin ved anvendelse av multiple antigener
SE8102558L (sv) Immunologisk bestemmningsmetod
ATE161581T1 (de) Monoklonale antikörper gegen humane pankreas- inselzellen
KR970707157A (ko) 항체의 특정 클래스에 특이적인 간섭 억제 시약(interference-suppressing reagent specific to certain classes of antibodies)
EP0346119A3 (en) Anti-fc assay for detection of antibodies
ATE98777T1 (de) Verfahren zur suche und identifizierung von erythrozytaeren antikoerpern mit hilfe der festphasen-methode.
DE69512909D1 (de) Festphasen-filtrationsverfahren zur antigen- und antikörperprüfung in der blutgruppen-serologie, und testsatz
WO2000034790A3 (de) Verfahren zum nachweis von antikörpern oder antigenen sowie zur blutgruppenbestimmung
Ramshaw et al. Surface properties of cells involved in antibody-dependent cytotoxicity
ES2054686T3 (es) Equipo de inmunoensayo.
SE8302329D0 (sv) T-cell-leukemiantigener, sett for framstellning derav och for analys av antikroppar
DK0599803T3 (da) Fremgangsmåde til påvisning af antistoffer og antigener
DE3569161D1 (en) Process for assaying atl virus antibody and reagent therefore
DK582288A (da) Analysefremgangsmaade og saet til udfoerelse af fremgangsmaaden